pembrolizumab,ramucirumab
eli lilly,merck
['lung', 'east energy']
east energy trial: immunotherapy plus antiangiogenic therapy seems feasible in neoadjuvant lung cancer setting. proof of concept, safe and with pathological response higher than immunotherapy alone. ph 2 trial, proof of concept, confirmation needed. #asco23 
Born in Majorca. Medical oncologist. Clinical researcher. Focused in lung cancer. World citizen. Major concerns: human inequality and blue planet environment